|
Press Releases and Ad-hoc-Announcements 2007
December 10, 2007 |
|
MOLOGEN AG submits application for clinical studies with innovative cancer treatment dSLIM®
 more
|
November 14, 2007 |
|
MOLOGEN AG announces results for the first nine months of 2007
more
|
September 24, 2007 |
|
MOLOGEN AG: Patent for MIDGE-based vaccine against Leishmaniasis will be granted.
more
|
August 14, 2007 |
|
MOLOGEN AG reports results of first six months 2007.
more
|
August 08, 2007 |
|
MOLOGEN AG: Treatment permission granted for cancer therapy in India
more
|
June 04, 2007 |
|
MOLOGEN AG sets course for sustainable success
more
|
June 01, 2007 |
|
MOLOGEN AG sells Spanish subsidiary
more
|
May 15, 2007 |
|
MOLOGEN AG invests into pre-clinical studies in the first quarter of 2007
more
|
April 24, 2007 |
|
MOLOGEN AG launches new company website
more
|
March 29, 2007 |
|
MOLOGEN AG reports profit for fiscal year 2006
· 2006 most successful year in company history
· Multiplication of sales through
commercialization agreements
more
|
March 15, 2007 |
| MOLOGEN AG: Successful capital increase to finance clinical studies
more |
March 12, 2007 |
| MOLOGEN AG: Patent granted for innovative technology in China
more
further Informations about Leishmaniasis |
February 01, 2007 |
| MOLOGEN AG appoints new Chief Financial Officer
more |
January 08, 2007 |
| MOLOGEN AG to upscale and optimize production
of DNA molecule
more |
January 02, 2007
|
| MOLOGEN AG acquires innovative technology
more |
|
|
NEWSLETTER |
| To subscribe to our Newsletter please
 click here
|
|
|
PRESS
RELEASES 